Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Royce Smaller-Companies Growth Fund Service Class (RYVPX)

12.71
Net Asset Value
-0.08%
1 Day
+15.44%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.51%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund's investment adviser invests the fund's assets primarily in equity securities of companies with stock market capitalizations up to $7.5 billion that Royce believes have above-average growth prospects. Normally- the fund invests at least 80% of its net assets in equity securities of companies with stock market capitalizations up to $7.5 billion. Although the fund normally focuses on securities of U.S. companies- it may invest up to 25% of its net assets (measured at the time of investment) in securities of companies headquartered in foreign countries.

Performance

1 month-1.85% 3 years+7.82%
3 months+6.53% 5 years+13.11%
1 year+19.22% Since inception+11.58%
Data through --

Peer Comparisonvs. Small growth

 RYVPXCategory
Performance 5-yr return+13.11%+13.02%
Expense ratio1.51%1.29%
Risk 5 year sharpe ratio0.881.02
Net assets$393.0M$1.0B
Average market cap$1.8B$3.8B
Average P/E27.629.4
Portfolio turnover59%59%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyRoyce
Fund manager & tenureJames (Chip) Skinner / 13 Years
Minimal initial investment$2,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock77.70%
International stock9.12%
Cash8.82%
Fixed income4.37%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 20.73%
Financial service 18.96%
Hardware 14.48%
Business service 11.16%
Consumer service 10.62%
Top 10 Holdings
Portfolio weighting
IPGP IPG Photonics Corp1.95%
PLUS ePlus inc1.91%
QADA QAD Inc1.86%
SQ Square Inc1.73%
-- 1.70%
MTLS Materialise NV1.68%
NEO Neogenomics Inc1.65%
ALB Albemarle Corp1.63%
PCTY Paylocity Holding Corp1.63%
SUPN Supernus Pharmaceuticals Inc1.62%